DIN 02444275 — APO-NALTREXONE 50 MG
APO-NALTREXONE is a tablet of Naltrexone marketed by APOTEX INC. The full Naltrexone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02444275
- Brand name
- APO-NALTREXONE
- Active ingredient
- Naltrexone
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Opioid antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Naltrexone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02451883 | NALTREXONE HYDROCHLORIDE TABLETS USP | 50 MG | TABLET | STERINOVA INC. | MARKETED |
| 02213826 | REVIA | 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED |